Wren Laboratories
Biotechnology Research • 
Branford, Connecticut, United States • 11-20 Employees
Company overview
| Headquarters | Branford, Connecticut, United States |
| Phone number | +12032083464 |
| Website | |
| NAICS | 541714 |
| SIC | 807 |
| Keywords | Personalized Medicine, Lung Cancer, Prostate Cancer, Biomarkers, Cancer, Diagnosis, Pancreatic Cancer, Colorectal Cancer, Breast Cancer, Molecular Diagnostics, AI, Machine Learning, Companion Diagnostics, Liquid Biopsy, Neuroendocrine Tumors, Myeloma, Minimal Residual Disease |
| Founded | 2013 |
| Employees | 11-20 |
| Socials |
Key Contacts at Wren Laboratories
Prasad Gawande
Senior Director Regulatory Affairs
Mark Kidd
Scientific Director At Wren Laboratories | Leader In Neuroendocrine Tumor Research And Diagnostics
Melissa Ferone
Director Of Quality Assurance
Mark Kidd
Laboratory Director
Wren Laboratories Email Formats
Wren Laboratories uses 2 email formats. The most common is {first name}{last name} (e.g., johndoe@wrenlaboratories.com), used 77.8% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}{last name} | johndoe@wrenlaboratories.com | 77.8% |
{first initial}{last name} | jdoe@wrenlaboratories.com | 22.2% |
About Wren Laboratories
Wren Laboratories is revolutionizing cancer diagnostics with advanced machine learning and liquid biopsy mRNA-based technology. Our goal is to provide precise, non-invasive diagnostics tailored to each patient's unique molecular profile, transforming early detection and surveillance of cancer for better patient outcomes. With over 100 patents and validation from more than 60 clinical studies, Wren has developed highly sensitive liquid biopsy mRNA gene expression-based assays. These innovative assays aid in cancer diagnosis, detect minimal residual disease (MRD), and predict tumor prognosis and therapeutic response. Our tests, including the NETest for neuroendocrine tumors and PROSTest for prostate cancer, leverage mRNA technology and AI/ML genomic assays for unparalleled molecular insights. This allows accurate detection of cancer markers, empowering personalized care. Our mRNA-based diagnostics are crucial in monitoring patients post-surgery or treatment. Wren also offers Biopharma services with AI/ML liquid biopsy genomic assays for research and companion diagnostics (CDx) development. Our RNA stabilizer tubes preserve whole blood at ambient temperature for up to 10 days, reducing clinical trial logistics. From our CLIA-certified, CAP-accredited, and NYS-licensed lab, our tests ensure high accuracy and reliability. For more information, visit our website and follow us for updates in non-invasive cancer diagnostics.
Wren Laboratories revenue & valuation
| Annual revenue | $500,000 |
| Revenue per employee | $25,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $1,600,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 11-20
Seniority
Employees
Employees by Department
Wren Laboratories has 12 employees across 6 departments.
Departments
Number of employees
Funding Data
Wren Laboratories has never raised funding before.
Wren Laboratories Tech Stack
Discover the technologies and tools that power Wren Laboratories's digital infrastructure, from frameworks to analytics platforms.
JavaScript libraries
Video players
Security
Hosting
Analytics
JavaScript libraries
JavaScript libraries
JavaScript libraries
JavaScript libraries
Maps
JavaScript libraries
Analytics
Australia
Italy
Belgium
United Kingdom
SpainFrequently asked questions
4.8
40,000 users
